Towards the development of a pediatric ventricular assist device

Harvey S Borovetz1, Stephen Badylak, J Robert Boston

  • 1Department of Bioengineering & McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA. borovetzhs@upmc.edu

Cell Transplantation
|July 11, 2006
PubMed

Insights

Researchers are developing a novel pediatric ventricular assist device (VAD) for infants and young children with heart failure. This innovative VAD aims to provide reliable, biocompatible chronic support, addressing critical treatment gaps in pediatric cardiac care.

Area of Science:

  • Biomedical Engineering
  • Pediatric Cardiology
  • Medical Device Development

Background:

  • Limited treatment options exist for pediatric ventricular failure in congenital and acquired heart diseases.
  • Existing VADs are not optimized for the unique physiological needs of children weighing 3-15 kg.

Purpose of the Study:

  • To review current pediatric cardiac assist treatment limitations.
  • To present the development of an innovative pediatric ventricular assist device (VAD) for chronic support in high-risk children.

Main Methods:

  • Development of a miniature mixed flow turbodynamic pump.
  • Incorporation of magnetic levitation technology for reduced blood trauma and thrombosis risk.
  • Collaboration between academic institutions (UoP, CMU), medical centers (UPMC, CHP), and industry partners.

Main Results:

  • Progress in designing a highly reliable and biocompatible VAD.
  • Focus on a specific pediatric population (3-15 kg, birth to 2 years).
  • The VAD is designed for 6-month chronic support.

Conclusions:

  • The developed pediatric VAD shows promise in addressing critical unmet needs in pediatric heart failure management.
  • The innovative design aims to improve patient outcomes by minimizing complications.
  • Ongoing development by a dedicated consortium is advancing pediatric VAD technology.

Related Concept Videos

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...